U.S. Stock News

CoreWeave overview and recent stock context CoreWeave (CRWV) has drawn fresh attention after a period of strong trading interest. The stock has shown recent momentum across the past week, month, and past 3 months, which puts its cloud infrastructure AI story back in focus. See our latest analysis for CoreWeave. At a share price of $117.43, CoreWeave’s recent run includes a 44.14% 1 month share price return and 48.05% year to date, alongside a 231.58% 1 year total shareholder return. These...

Chevron (CVX) is back in focus after a new oil discovery at the Bandit prospect in the Gulf of America, at a time when Middle East tensions and Venezuelan policy shifts are influencing global supply expectations. See our latest analysis for Chevron. Chevron's recent oil discovery comes after a strong run in the shares, with a year to date share price return of 17.54% and a 1 year total shareholder return of 43.20%. The 30 day share price return of 9.16% and 7 day share price return of 4.45%...

Shareholder proposal and board response Roper Technologies (ROP) is in focus after investor Robert Elliot Friedman submitted a proposal urging a tax-free spin-off of the Application and Network Software segments into separate public companies. The company has filed a definitive proxy statement recommending that shareholders vote against this spin-off review at the 19 May 2026 annual meeting, putting the current portfolio structure at the center of the discussion. See our latest analysis for...

Earlier in April 2026, Kyndryl announced it was selected by the North Carolina Division of Motor Vehicles to modernize its legacy COBOL-based systems, expand online and mobile services, and host a new environment on Microsoft Azure, while also rolling out new AI-driven offerings like Digital Twin for the Workplace and Sovereignty Solutioning. These moves highlight Kyndryl’s push into complex public-sector modernization and AI-enabled workplace services, reinforcing its role in managing...

SmartFinancial (SMBK) has put fresh numbers on the board for Q1 2026, coming off a recent quarter where Q4 2025 revenue was US$49.2 million and basic EPS was US$0.82, backed by net income of US$13.7 million. Over the past year, the company reported revenue moving from US$166.3 million on a trailing basis at Q4 2024 to US$192.7 million by Q4 2025. Trailing EPS increased from US$2.16 to US$3.00, framing this result against a backdrop of expanding earnings power and firmer profitability. See our...

Earlier in April 2026, Abbott Laboratories reported first-quarter sales of US$11.16 billion but lower net income of US$1.08 billion, while also facing a US$70 million jury verdict over Similac Special Care and unveiling new clinical data on its Cancerguard multi-cancer early detection blood test. The new Cancerguard data, showing complementary methylation and protein biomarker signals and recognition of the DETECT-A outcomes publication, strengthens Abbott’s position in emerging multi-cancer...

If you are wondering whether Netflix at around US$94.83 is a bargain or a trap, it helps to start by asking what the current price actually implies about the company. The stock has seen a 3.3% gain over the last 30 days, a 4.2% return year to date, but a 4.0% decline over the past year and an 8.1% pullback in the last week, which can change how investors think about both its growth potential and risk. Recent headlines have focused on Netflix's content pipeline, partnerships and competitive...

Houlihan Lokey (NYSE:HLI) has been appointed financial advisor to the Special Committee of Investcorp Credit Management BDC, Inc. The mandate covers a review of potential alternatives for Investcorp Credit Management BDC, Inc.'s business. This assignment underscores the firm's role in complex corporate review processes. For investors tracking NYSE:HLI, this new advisory role comes with the stock at a share price of $160.99. The company shows a mixed recent pattern, with a 3.2% return over...

Without a specific news headline to point to, State Street (STT) still gives investors plenty to think about, particularly given its recent share performance and the scale of its institutional-focused businesses. See our latest analysis for State Street. The recent share price return has been strong, with a 1 month gain of 23.13% and a 1 year total shareholder return of 91.48%. Together, these figures point to rising momentum as investors reassess both growth potential and risk around the...

Why Medpace Holdings Is On Investors’ Radar With no single headline event driving attention today, Medpace Holdings (MEDP) is drawing interest after a year of strong total return and recent price moves that contrast with its weaker past 3 months. See our latest analysis for Medpace Holdings. The recent 1 month share price return of 16.78% and 7 day gain of 5.43% hint that momentum is rebuilding after a 12.28% 3 month decline, while the 1 year total shareholder return of 82.86% and 3 year...

QUALCOMM overview and recent performance context QUALCOMM (QCOM) is back on investor radars as its shares trade around $137.52, with recent returns mixed across timeframes. This has prompted closer attention to how its core wireless technology and licensing businesses support the current valuation. See our latest analysis for QUALCOMM. Recent trading has seen a short burst of strength, with a 1 day share price return of 0.97% and 7 day return of 4.79%, set against a weaker 90 day share price...

If you are wondering whether Lockheed Martin's current share price reflects its true worth, the recent moves in the stock give you plenty to think about. The stock closed at US$581.28, with a 6.2% decline over the last 7 days and a 7.4% decline over the last 30 days, while still showing a 16.9% return year to date and a 30.3% return over 1 year. Recent headlines have focused on Lockheed Martin's role as a major defense contractor, including ongoing contract activity and its position in...

Why Wintrust Financial is on investors’ radar today Wintrust Financial (WTFC) has drawn attention after recent price moves, with the stock last closing at $148.79. Investors are weighing its $2,628.171m in revenue and $774.154m in net income against current valuation metrics. See our latest analysis for Wintrust Financial. Recent trading has been steady rather than explosive, with a 12.27% 1 month share price return and a 4.30% year to date share price return. The 1 year total shareholder...

Earlier this week, AST SpaceMobile confirmed that its BlueBird 7 satellite, launched on Blue Origin’s New Glenn-3 mission, was deployed into an orbit too low for sustained operations and will be de-orbited, with the satellite’s cost expected to be recovered through insurance. The loss of what would have been the company’s eighth low Earth orbit satellite tests AST SpaceMobile’s ability to keep its planned launch cadence and maintain momentum toward its direct-to-device cellular broadband...

Western Digital (WDC) is back in focus after reporting fiscal results that featured strong revenue growth, higher gross margins, and firm pricing in a tight supply backdrop for high-capacity storage products. See our latest analysis for Western Digital. The strong fiscal update comes on top of powerful share price momentum, with Western Digital’s 30 day share price return of 27.6% and year to date share price return of 99.3% adding to an already very large 1 year total shareholder return...

Littelfuse: recent performance snapshot Littelfuse (LFUS) has drawn increased attention after a recent share-price move, with the stock closing at US$395.38. Investors are weighing this level against its recent return profile and current fundamentals. See our latest analysis for Littelfuse. The recent 1.5% one-day share price return and strong 30-day share price return of 23.3% come on top of a 1-year total shareholder return of 156.2%. This indicates powerful momentum rather than a...

Corcept Therapeutics recently presented final overall survival data from its pivotal Phase 3 ROSELLA trial, showing that Lifyorli (relacorilant) plus nab-paclitaxel improved survival in adults with platinum-resistant ovarian cancer and is now FDA-approved and listed as a preferred regimen in NCCN Guidelines. An important milestone is that Lifyorli is the first FDA-approved selective glucocorticoid receptor antagonist, potentially opening a new treatment pathway for hard-to-treat gynecologic...

Wondering whether ServiceNow's current share price lines up with its underlying worth, or if the recent volatility is throwing you off? Over the past week the stock is up 12.0%, while the 30 day return is a 9.7% decline and the return so far this year is a 32.4% decline, with a 34.0% decline over the last 12 months and a 5.4% return across three years. These moves are unfolding against a backdrop where investors are reassessing high growth software names and rethinking how much they are...

Viasat recently entered Boeing’s technical evaluation process for its next-generation AERA electronically steered antenna, while also confirming an April 27, 2026 launch date for its ViaSat-3 F3 satellite aboard a SpaceX Falcon Heavy to expand high-capacity coverage across the Asia-Pacific region. Together, the Boeing evaluation and ViaSat-3 F3 launch timing highlight how Viasat is working to pair advanced in-flight hardware with broader global satellite capacity for commercial, fixed, and...

Investors may be wondering whether Atlantic Union Bankshares at around US$38.73 is still offering value or if most of the opportunity has already been priced in. The stock has returned 1.0% over the last week, 13.0% over 30 days, 9.0% year to date, and 64.4% over the past year, which naturally raises questions about how much of the story is already reflected in the share price. Recent attention on US regional banks has kept a spotlight on balance sheet strength, funding costs, and capital...

This article walks through what Meta Platforms at around US$670 a share might imply about its underlying value and whether expectations have already done most of the work. Meta's share price recently closed at US$670.91, with returns of 5.7% over the last 7 days, 13.0% over 30 days, 3.2% year to date, 38.9% over 1 year, 217.8% over 3 years and 123.1% over 5 years, which frames how sentiment has shifted over different timeframes. Recent headlines around Meta have continued to focus on its...

If you are wondering whether Boeing's current share price reflects its true worth, starting with a clear view of recent performance and valuation checks can help frame that question. Boeing recently closed at US$225.08, with returns of 1.3% over 7 days, 15.4% over 30 days, a 1.2% decline year to date, and 41.3% over the last year, which may signal shifting expectations around both opportunity and risk. Recent news coverage has focused on Boeing's ongoing operational progress and its role...

Investors may be wondering if Dow at around US$36.77 is offering good value right now, or if the strong run has already priced in the story. The share price is up 51.5% year to date and 39.6% over the last year, while the past 3 and 5 year returns of 20.7% and 22.3% are weaker. There has also been a recent 7 day move of 8.3% lower and a flat 0.3% return over the last 30 days. Recent coverage of Dow has focused on its role in the wider chemicals sector and how investors are reassessing...

Dynex Capital (DX) has just reported new figures, with recent quarters showing total revenue moving from US$60.3 million in Q4 2024 to US$202.0 million in Q4 2025 and basic EPS shifting from US$0.61 to US$1.17 over the same period, alongside trailing 12 month net income of US$308.9 million. Over the past year, revenue has tracked from US$150.4 million on a trailing basis in Q4 2024 to US$372.1 million by Q4 2025, while trailing EPS has moved from US$1.50 to US$2.49. These figures provide a...